Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is not routinely available on the NHS in Northern Ireland for weight management at present. Commissioning of tirzepatide follows a devolved path, and the phased rollout that began in England during 2025 has not been replicated in Northern Ireland on the same timetable. If you live in Northern Ireland and are waiting to see what NHS access looks like, the honest answer is: criteria, timelines and local commissioning decisions differ from those in England, and the picture is still developing. As a prescription-only medicine, Mounjaro requires a prescriber's assessment regardless of which route you take.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When NICE published TA1026 in December 2024, recommending tirzepatide for adults with a BMI of 35 or above and at least one weight-related comorbidity, that recommendation applied to NHS England. Northern Ireland, like Scotland and Wales, runs its own health service and makes its own commissioning decisions. The broader NHS picture for Mounjaro across the UK is one of phased, region-by-region rollout rather than a single switch being flipped.
In England, NHS tirzepatide prescribing opened to a narrow cohort from June 2025 (BMI 40 or above with four or more qualifying conditions) and expanded to a second cohort from June 2026. Northern Ireland has not published an equivalent phased rollout plan on the same timetable. That doesn't mean it won't happen; it means the local Department of Health sets its own pace, and patients in Northern Ireland should check with their GP about current local guidance rather than assuming English commissioning dates apply to them.
For context on how Scotland handles this separately, the NHS Scotland position on Mounjaro follows a similarly distinct path.
Even where formal NHS commissioning hasn't launched, your GP is a useful first port of call. They can tell you whether any local pathway exists, whether you'd qualify under draft criteria, and whether a referral to a specialist weight management service might open a door. Specialist services in Northern Ireland may have access through their own formularies in some cases.
Bear in mind that NHS Mounjaro prescribing anywhere in the UK sits within strict eligibility bands. The qualifying weight-related conditions NICE names are: type 2 diabetes, high blood pressure, dyslipidaemia, obstructive sleep apnoea, and cardiovascular disease. Lower BMI thresholds apply for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, reflecting UK guidance on ethnicity and BMI. Your GP will also need to discuss wraparound diet and activity support, which forms part of any NHS pathway.
Wales has its own distinct position too, you can read more about Mounjaro on the NHS in Wales if that's relevant to you or someone you know.
For people in Northern Ireland who don't meet NHS criteria, who would wait too long, or for whom a GP referral isn't imminent, a private prescription from a GPhC-registered online pharmacy is the legal alternative. The medicine is identical (same Eli Lilly KwikPen, same licensed UK supply chain) and the clinical requirements are the same: a prescriber must assess you and decide whether Mounjaro is appropriate before anything is dispensed.
If you're weighing up cost, the detailed cost and access breakdown for Northern Ireland is worth reading alongside this page. Private prices have shifted since Eli Lilly raised UK list prices from September 2025, and those who want to buy Mounjaro online will find market rates for a four-week pen broadly ranging from around £149 to over £300 depending on dose and provider, as reported at the time. That context matters when comparing services.
Wondering about the tirzepatide question more broadly? The NHS availability of tirzepatide across the UK covers the full picture, including what happens when you move between nations.
The MHRA has repeatedly warned about fake weight-loss pens circulating online. In October 2025 the first illicit UK manufacturing site producing counterfeit tirzepatide was raided, and enforcement across 2025 resulted in seizures of roughly 20 million doses of illegally traded weight-loss medicines with a street value of around £45 million. Suspect sellers can be reported directly to the MHRA via the Yellow Card scheme. Red flags include prices well below the market range, sellers offering these medicines without a prescription, and anyone advertising on social media with no verifiable pharmacy registration.
The GPhC register is the definitive check. Search by name or registration number at pharmacyregulation.org/registers, a legitimate online pharmacy will appear there with its premises number. Our GPhC premises registration is 9012878, verifiable at that link. Every consultation at nume is reviewed the same day by a GPhC-registered Independent Prescriber: a real clinician reads your answers, not a piece of software. Orders placed before midday (roughly the same window as getting something in the post before the school run) are dispatched the same working day once approved, arriving free the next working day by tracked DPD in plain packaging.
If you'd like to explore what's currently available for weight management, our weight-loss treatment overview covers both Mounjaro and Wegovy with full eligibility details. When you're ready to take the next step, our prescribers are here to help you work out whether treatment is right for you, speak to our prescribers through a free consultation today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.